Publicaciones en colaboración con investigadores/as de Universidad de Murcia (13)

2023

  1. Asthma management and control in children, adolescents, and adults in 25 countries: a Global Asthma Network Phase I cross-sectional study

    The Lancet Global Health, Vol. 11, Núm. 2, pp. e218-e228

2022

  1. The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study

    European Respiratory Journal, Vol. 60, Núm. 3

2021

  1. Childhood wheezing phenotypes and their association to perinatal factors: a longitudinal study

    Allergologia et immunopathologia, Vol. 49, Núm. 3, pp. 8-16

2016

  1. Factors associated to recurrent wheezing in infants under one year of age in the province of Salamanca, Spain: Is intervention possible? A predictive model

    Allergologia et Immunopathologia, Vol. 44, Núm. 5, pp. 393-399

2012

  1. Study of wheezing and its risk factors in the first year of life in the Province of Salamanca, Spain. The EISL Study

    Allergologia et Immunopathologia, Vol. 40, Núm. 3, pp. 164-171

2007

  1. Consenso sobre tratamiento del asma en pediatría

    Anales de Pediatria, Vol. 67, Núm. 3, pp. 253-273

2006

  1. Seasonal variations in asthma quality of life of Spanish asthmatic children (ESCAPE study)

    Annual Congress 2006 - Paediatric asthma and quality of life

2005

  1. How pediatricians in Spain manage the first acute wheezing episode in an atopic infant. Results from the TRAP study

    Allergologia et Immunopathologia, Vol. 33, Núm. 6, pp. 317-325

2004

  1. The use of spirometers and peak flow meters in the diagnosis and management of asthma among Spanish pediatricians. Results from the TRAP study

    Pediatric Allergy and Immunology, Vol. 15, Núm. 4, pp. 365-371

2002

  1. In vitro activity of linezolid, synercid and telithromcin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus

    International Journal of Antimicrobial Agents, Vol. 20, Núm. 1, pp. 61-64

2001

  1. Molecular diversity of quinolone resistance in genetically related clinical isolates of Staphylococcus aureus and susceptibility to newer quinolones

    Journal of Antimicrobial Chemotherapy, Vol. 47, Núm. 2, pp. 157-161

2000

  1. Actividad de nuevas quinolonas frente a aislamientos clinicos de Corynebacterium spp

    Revista Espanola de Quimioterapia, Vol. 13, Núm. 3, pp. 267-270

  2. Actividad in vitro de nuevas quinolonas frente a cepas clinicas de Staphylococcus aureus silvestres y con mutaciones caracterizadas e n gyrA, gyrB y grlA

    Revista Espanola de Quimioterapia, Vol. 13, Núm. 3, pp. 271-275